Abbott Laboratories - Depakote

Abbott allegedly engaged in unfair and deceptive practices when it marketed its drug, Depakote, for treatments that were not approved by the FDA. Depakote is approved for treatment of seizure disorders, mania associated with bipolar disorder and prophylaxis of migraines, but the State alleged Abbott marketed the drug for treating unapproved uses, including schizophrenia, agitated dementia and autism. As a result of the investigation, Abbott has agreed to significantly change how it markets Depakote and to cease promoting off-label uses, which was in violation of the Tennessee Consumer Protection Act. This was a multistate case...Abbott Laboratories filings.

E-Books

This multistate lawsuit against three of the nation's largest book publishers – Penguin, Simon & Schuster, and Macmillan – and Apple Inc., alleges they colluded to fix the sales prices of electronic books (e-books). The suit, filed in U.S. District Court in Austin, Texas, cites the defendants for violating the States' antitrust laws and the federal Sherman Antitrust Act...E-Books filings.

Skechers

The State alleges that Skechers made health-related claims in the marketing of its line of rocker-bottom shoe products including Shape-ups, Tone-ups, and the Skechers Resistance Runner that were not adequately substantiated at the time the claims were made...Skechers filings.